表紙
市場調查報告書

數位病理學系統的全球市場

Digital Pathology Systems

出版商 Global Industry Analysts, Inc. 商品編碼 269628
出版日期 內容資訊 英文 620 Pages
商品交期: 最快1-2個工作天內
價格
數位病理學系統的全球市場 Digital Pathology Systems
出版日期: 2020年08月01日內容資訊: 英文 620 Pages
簡介

本報告提供全球數位病理學系統市場相關調查,彙整市場趨勢與產品概要,各地區趨勢,及打入市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 免疫化學:概要
    • 研究抗體市場
    • 購買決策影響因素
    • 美國壟斷全球免疫化學市場
    • 新興市場潛力巨大
    • 目錄抗體:最大市場區隔
    • 自訂抗體
    • 一級塗料抗體壟斷市場
    • 競爭模式數位病理學系統:準確度,效率分析,降低成本
    • 促進工作流程的效率和降低成本的需求
    • 已開發國家壟斷
    • 新興國家的急速成長 其他
  • 競爭環境
    • 競爭市場
    • Leica壟斷市場
    • Philips的IntelliSite病理學系統:先進的數位病理學系統
  • 推動市場的要素,趨勢,課題
  • 產品概要
    • 病理學的簡介
    • 數位病理學:電腦實現的病理學流程
    • 零組件
  • 產品引進/技術創新
  • 近幾年的產業活動
  • 全球市場參與企業
    • 3DHISTECH Ltd.
    • Apollo Enterprise Imaging Corp.
    • Carl Zeiss AG
    • Corista LLC
    • Definiens AG
    • HAMAMATSU PHOTONICS
    • Huron Digital Pathology, Inc.
    • Leica Biosystems Nussloch GmbH
    • MikroScan Technologies, Inc.
    • Olympus Corporation
    • Philips Healthcare
    • Pixcelldata Ltd.
    • Ventana Medical Systems, Inc.
    • VMscope GmbH
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6740

COVID-19 Encourages Fully-Actioned Digital Strategies. Digital Pathology Systems Spikes by 18.3%

The global market for Digital Pathology Systems is expected to witness demand spike by 18.3% in the year 2020 highlighting a US$89.1million gains in annual revenue. Thereafter the market is expected to accelerate further and reach US$1.4 billion by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027.Pathology plays a huge role in the healthcare system and is a key part of clinical decision support. The pandemic has catalyzed the urgency of going digital and health systems are responding at lightning speeds. From telemedicine, wearable`s, IR monitoring to automation via use of robots, technology adoption is swift to ensure uninterrupted non-COVID care delivery with minimal infection risks. Deployment of IT is also gaining swift momentum as evidenced by rising demand for cloud solutions; analytics; sustainable supply chain solutions; EMR, EHR & digital pathology systems. With stay-at-home restrictions and the FDA`s decision to relax existing guidelines, various anatomic pathologists are embracing digital pathology to review images and slides from home. COVID-19 has resulted in dramatic decline in specimen referrals and associated revenues at anatomic pathology laboratories and groups. With the pandemic curtailing all but the most urgent cancer treatments and surgeries, histology laboratories are typically receiving extremely challenging tissue specimens for processing. In addition, there is a growing shortage of pathologists worldwide, with medical students entering the field failing to keep pace with the rate of retiring pathologists. Moreover, the strict physical distancing norms imposed to curb the spread of COVID-19 have led pathologists to stay of the lab.

However, amid the COVID-19 outbreak, new rules have been developed for allowing the increased usage of digital pathology and reading and reviewing of pathology slides and test results remotely, provided the test was initially performed in a CLIA-authorized laboratory. The pandemic prompted the CMS to ease restrictions for allowing pathologists to work and review pathology images remotely to reduce the risk of exposure to the virus. Applicable during the pandemic, the decision is bound to push capacity by supporting remote review of clinical results, laboratory data and pathology slides. The US FDA has temporarily eased guidelines pertaining to digital pathology services for encouraging medical professionals to remotely review scanned slides during COVID-19. The adoption of digital pathology is anticipated to reduce the exposure of pathologists to the virus and prevent disruption to critical pathology services. The new policy is applicable to Class-II digital pathology devices, and follows the CMS` decision to provide pathologists with the flexibility to remotely review clinical data, pathology studies and results during the outbreak. Prior to the COVID-19 pandemic, CMS guidelines under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 prohibited clinicians from making primary diagnoses remotely. The regulation made it mandatory for pathologists to work in healthcare settings, hospitals or clinical laboratories holding the CLIA license. However, the pandemic prompted the CMS to suspend these requirements and allow pathologists to interpret and review cases remotely. The new policy from the FDA also allows the use of consumer monitors instead of medical-grade monitors. Pathologists can access images remotely over a secure VPN Internet connection to make diagnosis. In addition, the agency is making efforts to ensure access to remote digital pathology systems or devices amid the pandemic.

In short, although the world is in recession, it is not doomsday for digital health companies and VC funding will continue to increase given the unprecedented demand for digital health technology solutions. Future growth in the market will be driven by ever growing workload of pathologists; growing emphasis on quality of care and the resulting need for efficient, faster and cost-effective methods for accurate pathological assessment; and need for compliance with regulatory standards related to information management. Few of the benefits of digital pathology driving its adoption include digitalization of workflows; unification of patient data for more informed decision making; exposure to new clinical insights and data which adds to the volume of available expert knowledge; enables multi-disciplinary care by connecting multiple medical teams; enhanced workflow efficiency, reduced costs of operating pathological processes, quicker acquisition of high resolution images, and faster and accurate diagnosis. As healthcare moves to a value based system, zero tolerance to innate delays built into traditional pathology processes will drive growth of digital pathology systems. Focus on developing coherent and sustainable plans to address healthcare needs of the masses will drive increased investments in healthcare IT, especially in developing countries. Fully automated digital pathology are poised to witness strong growth in demand amid the rising emphasis on lab automation. Developments in laboratory information management system (LIMS) and network connectivity and speeds to enable digital pathology deliver on its promise of reduced diagnostic time in comparison with traditional microscopy will also be crucial to growth in the market. In addition, focus on disease prevention, early diagnosis and intervention will remain evergreen factors driving routine use of digital pathology services.

Competitors identified in this market include, among others,

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • Carl Zeiss AG
  • Corista LLC
  • Definiens AG
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology Inc.
  • Leica Biosystems Nussloch GmbH
  • MikroScan Technologies Inc.
  • Olympus Corporation
  • Philips Healthcare
  • Pixcelldata Ltd.
  • Ventana Medical Systems Inc.
  • VMscope GmbH.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
    • EXHIBIT 1: Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
    • EXHIBIT 2: % Share VC Investments by Category for 2020
    • FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
    • COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
    • Future Outlook of Pathology Post-COVID-19
    • Digital Pathology: An Introduction
    • Key Digital Pathology Tools
    • Market Outlook
    • US and Europe Maintain Dominance
    • Emerging Markets to Experience Strong Growth
    • Scanners Lead Digital Pathology Market
    • Software Segment Post Strong Growth
    • Disease Diagnosis: Major Application of Digital Pathology Systems
    • Telepathology Experiences Strong Growth
    • Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
    • EXHIBIT 3: Global Digital Pathology Systems Market by End-Use: 2020
    • Major Issues Hampering Adoption of Digital Pathology Systems
    • Competitive Landscape
    • EXHIBIT 4: Market Share of Leading Players in Digital Pathology Systems Market: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Advancements Drive Adoption of Digital Pathology Systems
    • Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
    • EXHIBIT 5: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
    • Advantages of AI-Powered Digital Pathology
    • Digital Pathology Benefits Drug Discovery Process
    • Need for Early Diagnosis Puts Focus on Digital Pathology
    • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
    • EXHIBIT 6: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 7: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • EXHIBIT 8: Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
    • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
    • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
    • Clinical Research Continues to be Core Vertical for Digital Pathology
    • Digital Imaging and Robotic Light Microscopy Boost Growth
    • Computational Pathology for Leading-Edge Image Analytics
    • Cloud Platform Gains Momentum
    • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
    • Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
    • EXHIBIT 9: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Increased Focus on Companion Diagnostics to Benefit Market Growth
    • Improving Healthcare & Research Expenditure to Support Growth
    • EXHIBIT 10: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Aging Population: A Key Opportunity Indicator
    • EXHIBIT 11: Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
    • EXHIBIT 12: Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
    • EXHIBIT 13: Global Cancer Deaths by Age Group (in %) for 2019
    • Challenges Facing Digital Pathology Systems Market
    • High Costs
    • Workflow Integration with Other Related Functions
    • Other Issues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 3: World 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 6: World 12-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 9: World 12-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 12: World 12-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 15: World 12-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 18: World 12-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 21: World 12-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 24: World 12-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 27: World 12-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • COVID-19 Triggers Demand for Digital Pathology
    • Market Overview
    • Increasing Pressure on Pathological Labs: Cornerstone for Growth
    • Market Analytics
    • TABLE 28: USA Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 30: USA 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 33: USA 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 36: USA 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 39: Canada 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 42: Canada 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 45: Canada 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • JAPAN
    • Market Overview
    • Market Analytics
    • TABLE 46: Japan Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 48: Japan 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 51: Japan 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 54: Japan 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • CHINA
    • Market Overview
    • Market Analytics
    • TABLE 55: China Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 57: China 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 60: China 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 63: China 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • EUROPE
    • Market Overview
    • Market Analytics
    • TABLE 64: Europe Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 65: Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 66: Europe 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 69: Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 72: Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 75: Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 78: France 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 81: France 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 84: France 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 87: Germany 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 90: Germany 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 93: Germany 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 96: Italy 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 99: Italy 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 102: Italy 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 105: UK 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 108: UK 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 111: UK 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 114: Spain 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 117: Spain 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 120: Spain 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 123: Russia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 126: Russia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 129: Russia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 132: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 135: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 138: Rest of Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ASIA-PACIFIC
    • Market Overview
    • Market Analytics
    • TABLE 139: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 140: Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 141: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 144: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 147: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 150: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 153: Australia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 155: Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 156: Australia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 159: Australia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • INDIA
    • Market Overview
    • Inadequate Infrastructure Impedes Adoption of Telepathology
    • Market Analytics
    • TABLE 160: India Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 162: India 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 165: India 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 167: India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 168: India 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 170: South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 171: South Korea 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 173: South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 174: South Korea 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 176: South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 177: South Korea 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 179: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 180: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 182: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 183: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 185: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 186: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 188: Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 189: Latin America 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 191: Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 192: Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 194: Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 195: Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 197: Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 198: Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 200: Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 201: Argentina 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 203: Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 204: Argentina 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 206: Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 207: Argentina 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 209: Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 210: Brazil 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 212: Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 213: Brazil 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 215: Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 216: Brazil 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 218: Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 219: Mexico 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 221: Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 222: Mexico 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 224: Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 225: Mexico 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 227: Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 228: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 230: Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 231: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 233: Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 234: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 236: Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 237: Middle East 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 239: Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 240: Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 242: Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 243: Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 245: Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 246: Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 248: Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 249: Iran 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 251: Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 252: Iran 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 253: Iran Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 254: Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 255: Iran 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 257: Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 258: Israel 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 260: Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 261: Israel 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 262: Israel Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 263: Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 264: Israel 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 266: Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 267: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 269: Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 270: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 272: Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 273: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 275: UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 276: UAE 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 278: UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 279: UAE 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 280: UAE Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 281: UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 282: UAE 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 284: Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 285: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 287: Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 288: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 290: Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 291: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 293: Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 294: Africa 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 296: Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 297: Africa 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 298: Africa Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 299: Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 300: Africa 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 74